Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging

Peter T. Nelson, Yuriko Katsumata, Kwangsik Nho, Sergey C. Artiushin, Gregory A. Jicha, Wang Xia Wang, Erin L. Abner, Andrew Saykin, Walter A. Kukull, Disease Neuroimaging Initiative (ADNI) Alzheimer’s Disease Neuroimaging Initiative (ADNI), David W. Fardo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We report evidence of a novel pathogenetic mechanism in which thyroid hormone dysregulation contributes to dementia in elderly persons. Two single nucleotide polymorphisms (SNPs) on chromosome 12p12 were the initial foci of our study: rs704180 and rs73069071. These SNPs were identified by separate research groups as risk alleles for non-Alzheimer’s neurodegeneration. We found that the rs73069071 risk genotype was associated with hippocampal sclerosis (HS) pathology among people with the rs704180 risk genotype (National Alzheimer’s Coordinating Center/Alzheimer’s Disease Genetic Consortium data; n = 2113, including 241 autopsy-confirmed HS cases). Furthermore, both rs704180 and rs73069071 risk genotypes were associated with widespread brain atrophy visualized by MRI (Alzheimer’s Disease Neuroimaging Initiative data; n = 1239). In human brain samples from the Braineac database, both rs704180 and rs73069071 risk genotypes were associated with variation in expression of ABCC9, a gene which encodes a metabolic sensor protein in astrocytes. The rs73069071 risk genotype was also associated with altered expression of a nearby astrocyte-expressed gene, SLCO1C1. Analyses of human brain gene expression databases indicated that the chromosome 12p12 locus may regulate particular astrocyte-expressed genes induced by the active form of thyroid hormone, triiodothyronine (T3). This is informative biologically, because the SLCO1C1 protein transports thyroid hormone into astrocytes from blood. Guided by the genomic data, we tested the hypothesis that altered thyroid hormone levels could be detected in cerebrospinal fluid (CSF) obtained from persons with HS pathology. Total T3 levels in CSF were elevated in HS cases (p < 0.04 in two separately analyzed groups), but not in Alzheimer’s disease cases, relative to controls. No change was detected in the serum levels of thyroid hormone (T3 or T4) in a subsample of HS cases prior to death. We conclude that brain thyroid hormone perturbation is a potential pathogenetic factor in HS that may also provide the basis for a novel CSF-based clinical biomarker.

Original languageEnglish (US)
Pages (from-to)841-858
Number of pages18
JournalActa Neuropathologica
Volume132
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Sclerosis
Genomics
Thyroid Hormones
Cerebrospinal Fluid
Astrocytes
Genotype
Triiodothyronine
Alzheimer Disease
Brain
Single Nucleotide Polymorphism
Chromosomes
Databases
Pathology
Genes
Protein Transport
Thyroxine
Neuroimaging
Atrophy
Dementia
Autopsy

Keywords

  • Braineac
  • CARTS
  • HS-Aging
  • KATP
  • SUR2
  • TDP-43

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Nelson, P. T., Katsumata, Y., Nho, K., Artiushin, S. C., Jicha, G. A., Wang, W. X., ... Fardo, D. W. (2016). Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging. Acta Neuropathologica, 132(6), 841-858. https://doi.org/10.1007/s00401-016-1641-2

Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging. / Nelson, Peter T.; Katsumata, Yuriko; Nho, Kwangsik; Artiushin, Sergey C.; Jicha, Gregory A.; Wang, Wang Xia; Abner, Erin L.; Saykin, Andrew; Kukull, Walter A.; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Disease Neuroimaging Initiative (ADNI); Fardo, David W.

In: Acta Neuropathologica, Vol. 132, No. 6, 01.12.2016, p. 841-858.

Research output: Contribution to journalArticle

Nelson, PT, Katsumata, Y, Nho, K, Artiushin, SC, Jicha, GA, Wang, WX, Abner, EL, Saykin, A, Kukull, WA, Alzheimer’s Disease Neuroimaging Initiative (ADNI), DNIADNI & Fardo, DW 2016, 'Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging', Acta Neuropathologica, vol. 132, no. 6, pp. 841-858. https://doi.org/10.1007/s00401-016-1641-2
Nelson, Peter T. ; Katsumata, Yuriko ; Nho, Kwangsik ; Artiushin, Sergey C. ; Jicha, Gregory A. ; Wang, Wang Xia ; Abner, Erin L. ; Saykin, Andrew ; Kukull, Walter A. ; Alzheimer’s Disease Neuroimaging Initiative (ADNI), Disease Neuroimaging Initiative (ADNI) ; Fardo, David W. / Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging. In: Acta Neuropathologica. 2016 ; Vol. 132, No. 6. pp. 841-858.
@article{5a4b51d255c14bdbb4c098fd4dcc89ed,
title = "Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging",
abstract = "We report evidence of a novel pathogenetic mechanism in which thyroid hormone dysregulation contributes to dementia in elderly persons. Two single nucleotide polymorphisms (SNPs) on chromosome 12p12 were the initial foci of our study: rs704180 and rs73069071. These SNPs were identified by separate research groups as risk alleles for non-Alzheimer’s neurodegeneration. We found that the rs73069071 risk genotype was associated with hippocampal sclerosis (HS) pathology among people with the rs704180 risk genotype (National Alzheimer’s Coordinating Center/Alzheimer’s Disease Genetic Consortium data; n = 2113, including 241 autopsy-confirmed HS cases). Furthermore, both rs704180 and rs73069071 risk genotypes were associated with widespread brain atrophy visualized by MRI (Alzheimer’s Disease Neuroimaging Initiative data; n = 1239). In human brain samples from the Braineac database, both rs704180 and rs73069071 risk genotypes were associated with variation in expression of ABCC9, a gene which encodes a metabolic sensor protein in astrocytes. The rs73069071 risk genotype was also associated with altered expression of a nearby astrocyte-expressed gene, SLCO1C1. Analyses of human brain gene expression databases indicated that the chromosome 12p12 locus may regulate particular astrocyte-expressed genes induced by the active form of thyroid hormone, triiodothyronine (T3). This is informative biologically, because the SLCO1C1 protein transports thyroid hormone into astrocytes from blood. Guided by the genomic data, we tested the hypothesis that altered thyroid hormone levels could be detected in cerebrospinal fluid (CSF) obtained from persons with HS pathology. Total T3 levels in CSF were elevated in HS cases (p < 0.04 in two separately analyzed groups), but not in Alzheimer’s disease cases, relative to controls. No change was detected in the serum levels of thyroid hormone (T3 or T4) in a subsample of HS cases prior to death. We conclude that brain thyroid hormone perturbation is a potential pathogenetic factor in HS that may also provide the basis for a novel CSF-based clinical biomarker.",
keywords = "Braineac, CARTS, HS-Aging, KATP, SUR2, TDP-43",
author = "Nelson, {Peter T.} and Yuriko Katsumata and Kwangsik Nho and Artiushin, {Sergey C.} and Jicha, {Gregory A.} and Wang, {Wang Xia} and Abner, {Erin L.} and Andrew Saykin and Kukull, {Walter A.} and {Alzheimer’s Disease Neuroimaging Initiative (ADNI)}, {Disease Neuroimaging Initiative (ADNI)} and Fardo, {David W.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1007/s00401-016-1641-2",
language = "English (US)",
volume = "132",
pages = "841--858",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging

AU - Nelson, Peter T.

AU - Katsumata, Yuriko

AU - Nho, Kwangsik

AU - Artiushin, Sergey C.

AU - Jicha, Gregory A.

AU - Wang, Wang Xia

AU - Abner, Erin L.

AU - Saykin, Andrew

AU - Kukull, Walter A.

AU - Alzheimer’s Disease Neuroimaging Initiative (ADNI), Disease Neuroimaging Initiative (ADNI)

AU - Fardo, David W.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - We report evidence of a novel pathogenetic mechanism in which thyroid hormone dysregulation contributes to dementia in elderly persons. Two single nucleotide polymorphisms (SNPs) on chromosome 12p12 were the initial foci of our study: rs704180 and rs73069071. These SNPs were identified by separate research groups as risk alleles for non-Alzheimer’s neurodegeneration. We found that the rs73069071 risk genotype was associated with hippocampal sclerosis (HS) pathology among people with the rs704180 risk genotype (National Alzheimer’s Coordinating Center/Alzheimer’s Disease Genetic Consortium data; n = 2113, including 241 autopsy-confirmed HS cases). Furthermore, both rs704180 and rs73069071 risk genotypes were associated with widespread brain atrophy visualized by MRI (Alzheimer’s Disease Neuroimaging Initiative data; n = 1239). In human brain samples from the Braineac database, both rs704180 and rs73069071 risk genotypes were associated with variation in expression of ABCC9, a gene which encodes a metabolic sensor protein in astrocytes. The rs73069071 risk genotype was also associated with altered expression of a nearby astrocyte-expressed gene, SLCO1C1. Analyses of human brain gene expression databases indicated that the chromosome 12p12 locus may regulate particular astrocyte-expressed genes induced by the active form of thyroid hormone, triiodothyronine (T3). This is informative biologically, because the SLCO1C1 protein transports thyroid hormone into astrocytes from blood. Guided by the genomic data, we tested the hypothesis that altered thyroid hormone levels could be detected in cerebrospinal fluid (CSF) obtained from persons with HS pathology. Total T3 levels in CSF were elevated in HS cases (p < 0.04 in two separately analyzed groups), but not in Alzheimer’s disease cases, relative to controls. No change was detected in the serum levels of thyroid hormone (T3 or T4) in a subsample of HS cases prior to death. We conclude that brain thyroid hormone perturbation is a potential pathogenetic factor in HS that may also provide the basis for a novel CSF-based clinical biomarker.

AB - We report evidence of a novel pathogenetic mechanism in which thyroid hormone dysregulation contributes to dementia in elderly persons. Two single nucleotide polymorphisms (SNPs) on chromosome 12p12 were the initial foci of our study: rs704180 and rs73069071. These SNPs were identified by separate research groups as risk alleles for non-Alzheimer’s neurodegeneration. We found that the rs73069071 risk genotype was associated with hippocampal sclerosis (HS) pathology among people with the rs704180 risk genotype (National Alzheimer’s Coordinating Center/Alzheimer’s Disease Genetic Consortium data; n = 2113, including 241 autopsy-confirmed HS cases). Furthermore, both rs704180 and rs73069071 risk genotypes were associated with widespread brain atrophy visualized by MRI (Alzheimer’s Disease Neuroimaging Initiative data; n = 1239). In human brain samples from the Braineac database, both rs704180 and rs73069071 risk genotypes were associated with variation in expression of ABCC9, a gene which encodes a metabolic sensor protein in astrocytes. The rs73069071 risk genotype was also associated with altered expression of a nearby astrocyte-expressed gene, SLCO1C1. Analyses of human brain gene expression databases indicated that the chromosome 12p12 locus may regulate particular astrocyte-expressed genes induced by the active form of thyroid hormone, triiodothyronine (T3). This is informative biologically, because the SLCO1C1 protein transports thyroid hormone into astrocytes from blood. Guided by the genomic data, we tested the hypothesis that altered thyroid hormone levels could be detected in cerebrospinal fluid (CSF) obtained from persons with HS pathology. Total T3 levels in CSF were elevated in HS cases (p < 0.04 in two separately analyzed groups), but not in Alzheimer’s disease cases, relative to controls. No change was detected in the serum levels of thyroid hormone (T3 or T4) in a subsample of HS cases prior to death. We conclude that brain thyroid hormone perturbation is a potential pathogenetic factor in HS that may also provide the basis for a novel CSF-based clinical biomarker.

KW - Braineac

KW - CARTS

KW - HS-Aging

KW - KATP

KW - SUR2

KW - TDP-43

UR - http://www.scopus.com/inward/record.url?scp=84994201629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994201629&partnerID=8YFLogxK

U2 - 10.1007/s00401-016-1641-2

DO - 10.1007/s00401-016-1641-2

M3 - Article

C2 - 27815632

AN - SCOPUS:84994201629

VL - 132

SP - 841

EP - 858

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -